ENTER THE MM&M AWARDS 2008!




ENTER THE MM&M AWARDS 2008

Late deadline extended to Friday, June 6.

There is still time to enter. Don't miss your last chance to submit your best work. The deadline for submissions is June 6. Visit www.mmm-online.com/awards to submit your entry today.


New Drug Dossier

Click here to subscribe

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. 

TOP JOBS

To find out about the MM&M Careers Section contact:
Scott Dattoli at 646-638-6015

Webcast

How to Engage Online Consumers in Daily Health Management
Date/time: Available on demand
Click here to register for FREE

This event will offer expert insights on the importance of engaging consumers in regular healthcare management, and how marketers can achieve this. Topics will include the characteristics and behavior of the online audience, the role of women as family healthcare managers, overcoming hurdles that prevent consumer action and tools for daily healthcare management. There will also be an interactive Q and A session.

Sponsored by Everyday Health.

Get the job done with vendors from the MM&M Service Directory


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Connect with Direct Marketing Specialists


Subscribe Today


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

MM&M Career & Salary Survey Premium Edition

Are you making as much as your peers?

Complete the MM&M Career & Salary Survey 2008 now for a chance to win the latest Nintendo console. All responses will remain confidential. Click here to take the survey. 

 

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

IOM probe into conflicts of interest in CME, research ruffles feathers

Last week's meeting of an Institute of Medicine (IOM) committee gave some hope for a thaw in attitudes toward commercially supported CME, but supporters and providers remain anxious about the group's inquiry into conflicts of interest in medical research and medical education.
 

Pharma wants research partners, not data suppliers

Form true partnerships with your clients, keep them happy and make your recommendations short and sweet — that's the message from pharmaceutical companies to their marketing research suppliers and consultants, according to a new study by marketRx, a Cognizant Company.
 

Lilly denies NY Times Zyprexa report

Eli Lilly has denied the assertions of a recent New York Times article alleging that incoming CEO John Lechleiter encouraged off-label promotion of the company's embattled schizophrenia treatment Zyprexa (olanzapine) in an e-mail he sent in 2003.
 

AstraZeneca widens disclosure policy

As other drugmakers come under fire for being slow to release info on clinical trials and monetary donations, AstraZeneca plans to widen its disclosure policy at its US website in an effort to create greater transparency into how it conducts its business.
 

In Brief

Product news

Hawthorn Pharmaceuticals announced the FDA approval of the company's Granisol (granisetron HCl) oral solution. Granisol is an oral solution for the prevention of nausea and vomiting associated with cancer therapy.
 

People news

Stiefel Laboratories announced two senior staff promotions.
 

Company news

Baxter International announced that its board of directors has approved the repurchase of an additional $2 billion of the company's common stock to be executed upon completion of the company's existing share repurchase authorization. Baxter has less than $700 million of remaining authorization under its previous $2 billion share repurchase program that was authorized in March 2007.
 

Latest Features

Sales Force Report: Rep 2.0

By equipping all of its sales reps with interactive tools, AstraZeneca's field force has added valuable minutes to its sales calls and considerably improved its ability to cover multiple products in a single detail.
 

Blueprint for Branding Devices

David Paragamian emphasizes the importance of building master brands and exploring promotional channels
 

Measuring the Signal

There is no point in running a great journal ad if no one notices it. But how do you truly determine if the signal is cutting through the noise? Stephen Hellebusch tests the theory of signal detectability on a group of primary care physicians
 

Crafting Effective Ads

Once a product has been positioned and its brand story told, it's time to develop a creative concept. Cathy Su and Noah Pines look at marketing research techniques that help evolve visual executions, resulting in truly effective ads
 

Headliner: HCMA's Jay Bolling

Jay Bolling has a salesman's upbeat mien and smooth delivery, befitting the head of a new national trade group for medical marketers, a business getting squeezed from all sides.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.